Health • April 3, 2026
Breakthrough ALS study launches as drug aims to slow disease progression
Originally published on Fox News Health
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
Originally published on Fox News Health.
More good news
- Amid Spokane fires, local bootmaker turns headquarters into refuge for firefighters, distributes new shoes for free
- Town’s Beloved Santa Claus Delivers a Very Special Present to Someone in Need–His Donated Kidney
- That time you learn you've been lying to yourself.
- Man recreates a 30 years photo of him and his dad, with his son